Skip to content
NovAccess Global Logo
XSNX 0.00 0.00 0.00%
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
NovAccess Global Logo
XSNX 0.00 0.00 0.00%
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact
  • Home
  • Our Mission
  • Science & Tech
  • StemVax
  • Team
  • Investors
    • News
    • Publications
    • Press Releases
    • SEC Filings
    • Presentations
    • Contact

Category: NovAccess Global Press Releases

NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress

NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA

NovAccess Global Secures Worldwide Rights to Approved Patent

NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer

NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer

NovAccess Global Acquires StemVax Therapeutics from Innovest Global

XsunX, Inc. Changes Name to NovAccess Global Inc.

Innovest Global Announces Upcoming Conference Participation and Biotech Award

Innovest Board Approves Plan to Maximize Shareholder Value from Biotech and Industrial Initiatives

Innovest Global Provides December Shareholder Update Featuring Acquisition Update, Revenue Growth, Biotech Progress

← older
newer →

Revolutionary advances in the  understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors. NovAccess Global’s team of experts is working to strengthen the capability of the human body’s defense against cancer.

Youtube Facebook Twitter Linkedin

Privacy Policy

Forward-Looking Statements

Contact Us

  • info@novaccessglobal.com
  • Corporate HQ
  • 459 Columbus Ave. #607
    New York, NY 10025
  • Research & Development
  • 2265 E. Foothill Blvd, Pasadena, CA 91107

JOIN US

Stay up-to-date with our journey

Facebook Twitter Linkedin

Privacy Policy

Privacy Policy

Forward-Looking Statements